{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:27:45Z","timestamp":1787783265987,"version":"build-2784847793"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PTT"],"DOI":"10.2147\/ptt.s514249","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:45:10Z","timestamp":1744371910000},"page":"145-158","source":"Crossref","is-referenced-by-count":18,"title":["Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events"],"prefix":"10.2147","volume":"Volume 15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7454-1999","authenticated-orcid":true,"given":"Zeno","family":"Fratton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2781-6909","authenticated-orcid":true,"given":"Stefano","family":"Bighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4374-802X","authenticated-orcid":true,"given":"Luca","family":"Bettolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariachiara","family":"Arisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Buligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Stinco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Errichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,4]]},"container-title":["Psoriasis: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/102006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/102006","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T11:45:11Z","timestamp":1744371911000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/real-world-experience-of-bimekizumab-in-a-cohort-of-109-patients-over--peer-reviewed-fulltext-article-PTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ptt.s514249","relation":{},"ISSN":["2230-326X"],"issn-type":[{"value":"2230-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}